Termination of the licensing agreement authorizing marketing of one of the company’s premier products loomed near. However, the licensor was refusing to extend the term intending instead to appropriate the business. With the availability window rapidly closing, replacing the supplier became a necessity to avoid a no-stock situation.
David Mashaal, a US/INTL negotiation expert, sourced all available suppliers in search of one offering at least equal quality, adequate quantities, and a good chance for registration. He located and commenced negotiations with a major European producer to acquire selling rights for Asia.
David Mashaal, Senior Global Business Development Executive
By organizing and leading regulatory, marketing, and sales teams to assist in each step of the process, David promptly completed an agreement.
The company gained a superior cartridge-versus-vial product presentation, and the supplier enjoyed a substantial increase in market coverage. He employed the new supplier’s biosimilar pathway methodology to shorten registration time making the replacement product available in nine countries before the previous vendor’s inventories ran out.
Choosing the correct supplier was a big advantage. Offering a more visually and application-appealing product bumped sales 15% and improved patient compliance 80%.
Watch full video interview below.
Contact David Mashaal via LinkedIn or his Career WebFolio.
ViewPoint© is a production of The US AT Work Network© and Stewart, Cooper & Coon, a Human Capital Strategies Corporation. Contact: Fred Coon – 866-883-4200, Ext. 200, for more information.
© 2004-2023 Stewart, Cooper, & Coon, Inc. All rights reserved. Limited to personal use and allowable only if this copyright message is left intact. Any duplication, alteration, or publishing of this content without express company permission is prohibited. Contact fcoon@stewartcoopercoon.com.
See also: viewpoint, experts, interviews, solving, problems, workplace, topics, focused, decision, executive placement, executive search